| 股號 / 名稱 | 營業現金流 | 自由現金流 | 淨現金流 |
| BHC Bausch Health Companies Inc. | 21,365,231,859.2 | 18,909,824,615.68 | 16,773,301,429.76 |
| TSHA Taysha Gene Therapies, Inc. | -1,289,088,802.85 | -1,289,056,914.44 | 5,619,725,635.49 |
| 6472 保瑞 | 688,938,000 | 454,238,000 | 3,696,457,000 |
| AMPH Amphastar Pharmaceuticals, Inc. | 1,636,640,537.23 | 1,362,687,243.34 | 1,679,721,773.41 |
| PSNL Personalis, Inc. | -821,764,216.44 | -942,366,167.02 | 649,694,378.95 |
| 3705 永信 | 327,770,000 | 208,390,000 | 563,414,000 |
| SLGL SOL-GEL TECHNOLOGIES LTD. | -273,825,740.26 | -273,251,748.96 | 448,669,869.04 |
| 1795 美時 | 701,365,000 | 603,443,000 | 150,870,000 |
| 6461 益得 | -85,138,000 | -98,472,000 | 44,980,000 |
| ASMB Assembly Biosciences Inc | -493,887,628.41 | -493,887,628.41 | 37,181,881.12 |
| CPHI China Pharma Holdings Inc | -1,046,896.36 | 4,349,578.55 | |
| 1720 生達 | 226,316,000 | 98,372,000 | -11,394,000 |
| 6130 上亞科技 | -9,023,000 | -9,023,000 | -13,697,000 |
| SUPN Supernus Pharmaceuticals, Inc. | -153,383,231.71 | -171,495,846.18 | -156,763,402.72 |
| 4120 友華 | -305,129,000 | -376,627,000 | -185,264,000 |
| 4747 強生* | 14,405,000 | 2,196,000 | -765,190,000 |
| RDY Dr. Reddy's Laboratories Limited | -312,602,838.88 | -1,467,918,185.14 | -1,405,869,725.21 |
| TEVA Teva Pharmaceutical Industries Limited | 13,138,023,173.12 | 9,789,740,568.32 | -2,742,402,895.36 |
| BBIO BridgeBio Pharma, Inc. | -2,267,297,537.94 | -2,281,424,101.69 | -6,440,883,972.22 |
載入數據中...
最新要聞
和學名藥相關的產業概念股
學名藥概念股相關指標排名
學名藥每月營收
學名藥每股盈餘
學名藥每股淨值
學名藥損益表
學名藥總資產
學名藥負債和股東權益
學名藥現金流量表
學名藥利潤比率
學名藥營業費用率拆解
學名藥杜邦分析
學名藥ROE / ROA
學名藥經營週轉能力
學名藥營運週轉天數
學名藥現金股利發放率
學名藥財務結構比率
學名藥流速動比率
學名藥利息保障倍數
學名藥現金流量分析
學名藥營業現金流對淨利比
學名藥盈餘再投資比率
學名藥月營收成長率
學名藥營收成長率
學名藥毛利成長率
學名藥營業利益成長率
學名藥稅後淨利成長率
學名藥每股盈餘成長率
學名藥本益比評價
學名藥股價淨值比評價
學名藥現金股利殖利率
學名藥平均現金股息殖利率
學名藥董監持股比例
學名藥董監持股質押比例